Amneal Pharmaceuticals gets FDA approval for romidepsin injection solution

Amneal Pharmaceuticals (NASDAQ:AMRX) said on Thursday the US Food and Drug Administration has approved its romidepsin injection solution, 27.5 mg/5.5 mL, in...